Search results
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell...
Benzinga via Yahoo Finance· 7 months agoTuesday, the FDA said it received reports of patients developing T-cell malignancies, including...
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies
Zacks via Yahoo Finance· 7 months agoThe FDA has undertaken an investigation of T-cell malignancies in patients undergoing CAR T-cell...
FDA investigating cancer risk linked to CAR-T cell therapy
BioPharma Dive via Yahoo Finance· 7 months agoThe Food and Drug Adminsitration is investigating whether CAR-T cell therapies like Novartis’...
CAR-T for lupus: the ‘tip of the iceberg’ for cell therapy in autoimmune disease
BioPharma Dive via Yahoo Finance· 5 months agoSince a landmark paper in 2022, drugmakers have begun nearly a dozen trials of cell therapies for...
Bristol Myers (BMY) Announces CAR T Cell Therapy Breyanzi Data
Zacks via Yahoo Finance· 1 year agoBristol Myers' (BMY) CAR T cell therapy Breyanzi (lisocabtagene maraleucel) shows deep and durable...
Novartis licenses Legend cell therapy for lung cancer
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: Novartis is deepening its investment in cancer cell therapy, licensing an experimental...
Bristol Myers (BMY), TSVT CAR T-Cell Therapy to Face FDA's ODAC
Zacks via Yahoo Finance· 4 months agoBristol Myers (BMY) and its partner TSVT announce that the FDA's ODAC will meet in March to review...
APAC leaps ahead in adoptive cell therapy space
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe Asia Pacific (APAC) region is leading the charge for adoptive cell therapy studies, says Scotty Chung-Siu, a managing analyst at GlobalData. At the...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters via AOL· 4 days agoThe European Medicines Agency's (EMA) mandate, which echoes the one issued by the U.S. health...
US FDA investigating safety risk of CAR-T cancer therapies
Reuters via AOL· 7 months agoThe U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies...